1) human thrombin receptor precursor
凝血酶受体前体
2) thrombin receptor
凝血酶受体
1.
Immunolocalization of thrombin receptor expressed in human dental pulp cell and tissue;
凝血酶受体在人牙髓组织和细胞中表达的免疫组化研究
2.
AIM: To observe the effects of puerarin on the proliferation of vascular smooth muscle cells (VSMC) induced by thrombin and the effects of puerarin on the c-fos protein expression and thrombin receptor(TR)mRNA expression.
目的:通过建立凝血酶(T)诱导的血管平滑肌细胞(VSMC)增殖模型,观察葛根素对T诱导的VSMC增殖的影响,并进一步观察其对c- fos蛋白以及凝血酶受体(TR)mRNA表达的作用,旨在认识葛根素作用的分子机制。
3.
To study the effects of low molecule weight heparin(Fragmin) on the expression of thrombin receptor and extracellular matrix, we detected the expressions of type IV collagen as well as mRNA expressions of thrombin receptor in the remnant kidneys of the 5/6 nephrectomized rats treated with Fragmin.
探讨在肾小球硬化过程中 ,低分子量肝素治疗对细胞外基质和凝血酶受体表达的影响 ,用 5 6肾切除的方法诱导大鼠局灶节段性肾小球硬化模型并给予低分子量肝素治疗 2 0周 ,通过RT PCR和免疫组化法观察低分子量肝素对 5 6肾切除大鼠残肾组织中IV型胶原、凝血酶受体基因表达的影响。
3) prothrombin precursor
凝血酶前体
5) Des-carboxylated
血清凝血酶原前体蛋白
1.
【Objective】 To study the status of vitamin K in(LBKDB) infants and their mothers by Des-carboxylated Prothrombin(PIVKA-Ⅱ).
【目的】以血清凝血酶原前体蛋白(PIVK-Ⅱ)来研究晚发型维生素K缺乏性出血(late vitamin K deficiencybleeding,LVKDB)患儿及其母亲维生素K营养状况,观察不同剂量维生素K对PIVKA-Ⅱ的影响。
补充资料：前抗凝血酶
分子式：
CAS号：
性质：抗凝血酶的无活性前体。
CAS号：
性质：抗凝血酶的无活性前体。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条